Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 61 to 62 of 62 entries
Sorted by: Best Match Show Resources per page
Comparison of the Ketamine-Lidocaine and Fentanyl-Lidocaine in Postoperative Analgesia in Axillary Block in Upper Limb Fractures By Ultrasound Guidance.

Anesthesiology and pain medicine

Akhondzadeh R, Rashidi M, Gousheh M, Olapour A, Tasbihi B.
PMID: 32280613
Anesth Pain Med. 2019 Dec 01;9(6):e92695. doi: 10.5812/aapm.92695. eCollection 2019 Dec.

BACKGROUND: Regional anesthesia provides safe anesthesia for upper extremity surgery. Axillary plexus block approach for hand and forearm surgery is commonly used. The use of adjuvants in combination with local anesthetics for peripheral nerve blocks enhances the quality and...

Cite
Akhondzadeh R, Rashidi M, Gousheh M, et al. Comparison of the Ketamine-Lidocaine and Fentanyl-Lidocaine in Postoperative Analgesia in Axillary Block in Upper Limb Fractures By Ultrasound Guidance. Anesth Pain Med. 2019;9(6):e92695doi: 10.5812/aapm.92695.
Akhondzadeh, R., Rashidi, M., Gousheh, M., Olapour, A., & Tasbihi, B. (2019). Comparison of the Ketamine-Lidocaine and Fentanyl-Lidocaine in Postoperative Analgesia in Axillary Block in Upper Limb Fractures By Ultrasound Guidance. Anesthesiology and pain medicine, 9(6), e92695. https://doi.org/10.5812/aapm.92695
Akhondzadeh, Reza, et al. "Comparison of the Ketamine-Lidocaine and Fentanyl-Lidocaine in Postoperative Analgesia in Axillary Block in Upper Limb Fractures By Ultrasound Guidance." Anesthesiology and pain medicine vol. 9,6 (2019): e92695. doi: https://doi.org/10.5812/aapm.92695
Akhondzadeh R, Rashidi M, Gousheh M, Olapour A, Tasbihi B. Comparison of the Ketamine-Lidocaine and Fentanyl-Lidocaine in Postoperative Analgesia in Axillary Block in Upper Limb Fractures By Ultrasound Guidance. Anesth Pain Med. 2019 Dec 01;9(6):e92695. doi: 10.5812/aapm.92695. eCollection 2019 Dec. PMID: 32280613; PMCID: PMC7118445.
Copy Download .nbib Format: NLM
Cancer immunotherapy: Challenges and limitations.

Pathology, research and practice

Taefehshokr S, Parhizkar A, Hayati S, Mousapour M, Mahmoudpour A, Eleid L, Rahmanpour D, Fattahi S, Shabani H, Taefehshokr N.
PMID: 34952426
Pathol Res Pract. 2021 Nov 28;229:153723. doi: 10.1016/j.prp.2021.153723. Epub 2021 Nov 28.

Although cancer immunotherapy has taken center stage in mainstream oncology inducing complete and long-lasting tumor regression, only a subset of patients receiving treatment respond and others relapse after an initial response. Different tumor types respond differently, and even in...

Cite
Taefehshokr S, Parhizkar A, Hayati S, et al. Cancer immunotherapy: Challenges and limitations. Pathol Res Pract. 2021;229:153723doi: 10.1016/j.prp.2021.153723.
Taefehshokr, S., Parhizkar, A., Hayati, S., Mousapour, M., Mahmoudpour, A., Eleid, L., Rahmanpour, D., Fattahi, S., Shabani, H., & Taefehshokr, N. (2021). Cancer immunotherapy: Challenges and limitations. Pathology, research and practice, 229153723. https://doi.org/10.1016/j.prp.2021.153723
Taefehshokr, Sina, et al. "Cancer immunotherapy: Challenges and limitations." Pathology, research and practice vol. 229 (2021): 153723. doi: https://doi.org/10.1016/j.prp.2021.153723
Taefehshokr S, Parhizkar A, Hayati S, Mousapour M, Mahmoudpour A, Eleid L, Rahmanpour D, Fattahi S, Shabani H, Taefehshokr N. Cancer immunotherapy: Challenges and limitations. Pathol Res Pract. 2021 Nov 28;229:153723. doi: 10.1016/j.prp.2021.153723. Epub 2021 Nov 28. PMID: 34952426.
Copy Download .nbib Format: NLM
Showing 61 to 62 of 62 entries